Business Standard

Founded by 2 Gujaratis, US drug major Amneal eyes speciality biz in India

Indo-American brothers Chirag and Chintu Patel have built a $1.8-bn drug giant that is set to pip Sun Pharma as the fifth largest generics maker in the US

Indian destocking hits GSK consumer health care business
Premium

Apart from trade destocking in India, another key reason for a drop reported in consumer health care CER growth in the quarter was divestment of its beverage business in Nigeria

Sohini Das Ahmedabad
Two Indian-American brothers hailing from Gujarat, Chirag and Chintu Patel, have built a $1.8-billion drug major Amneal Pharmaceuticals in the US from scratch in around a decade and a half. After its recent merger with Impax Laboratories last month, the combined entity, with revenues of $1.75-1.85 billion, is close to pipping Indian giant Sun Pharmaceutical ($2 billion revenue in 2016-17) as the fifth-largest generics maker in the US. Amneal expects revenues to touch $2.6 billion by 2020.  

The brothers, who spent the first two decades of their lives among a 45-member joint family in India, are, however, cautious about

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in